Oxford Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $73K | Sell |
34,709
-125,064
| -78% | -$263K | 0.01% | 156 |
|
|
2019
Q4 | $869K | Buy |
159,773
+36,064
| +29% | +$196K | 0.02% | 949 |
|
|
2019
Q3 | $372K | Buy |
123,709
+29,013
| +31% | +$87.2K | 0.01% | 1372 |
|
|
2019
Q2 | $354K | Buy |
94,696
+6,663
| +8% | +$24.9K | 0.01% | 1405 |
|
|
2019
Q1 | $354K | Sell |
88,033
-4,568
| -5% | -$18.4K | 0.01% | 1360 |
|
|
2018
Q4 | $340K | Buy |
92,601
+28,665
| +45% | +$105K | 0.01% | 1349 |
|
|
2018
Q3 | $550K | Buy |
63,936
+8,902
| +16% | +$76.6K | 0.01% | 1281 |
|
|
2018
Q2 | $607K | Buy |
55,034
+1,682
| +3% | +$18.6K | 0.01% | 1263 |
|
|
2018
Q1 | $615K | Buy |
53,352
+29,523
| +124% | +$340K | 0.01% | 1157 |
|
|
2017
Q4 | $256K | Buy |
+23,829
| New | +$256K | 0.01% | 1381 |
|
|
2017
Q2 | – | Sell |
-13,809
| Closed | -$287K | – | 1508 |
|
|
2017
Q1 | $287K | Buy |
+13,809
| New | +$287K | 0.01% | 1208 |
|